Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
34.43+1.49 (+4.52%)
At close: 04:00PM EST
34.43 0.00 (0.00%)
After hours: 04:00PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-317,758
-225,334
-152,142
-128,389
Depreciation & amortisation
4,695
2,731
397
177
Stock-based compensation
34,888
23,941
10,521
8,311
Change in working capital
24,890
15,541
17,707
343
Accounts payable
9,641
7,278
1,417
607
Other working capital
-263,025
-189,049
-136,694
-71,819
Other non-cash items
-4,242
694
2,445
2,396
Net cash provided by operating activities
-258,453
-178,546
-117,802
-70,720
Cash flows from investing activities
Investments in property, plant and equipment
-4,572
-10,503
-18,892
-1,099
Purchases of investments
-1,138,407
-425,158
-
0
Net cash used for investing activities
-788,332
-435,661
-18,892
-1,099
Cash flows from financing activities
Common stock issued
573,157
328,251
0
60,058
Other financing activities
36,894
30,895
440,835
-
Net cash used provided by (used for) financing activities
623,376
423,602
440,835
60,058
Net change in cash
-423,409
-190,605
304,141
-11,761
Cash at beginning of period
673,876
387,823
83,682
95,443
Cash at end of period
250,467
197,218
387,823
83,682
Free cash flow
Operating cash flow
-258,453
-178,546
-117,802
-70,720
Capital expenditure
-4,572
-10,503
-18,892
-1,099
Free cash flow
-263,025
-189,049
-136,694
-71,819